Global X Genomics & Biotechnology ETF
GNOM
58 hedge funds and large institutions have $111M invested in Global X Genomics & Biotechnology ETF in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 9 closing their positions.
65% more capital invested
Capital invested by funds: $67.2M → $111M (+$43.6M)
4.99% more ownership
Funds ownership: 10.77% → 15.76% (+5%)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
3% less funds holding
Funds holding: 60 → 58 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$56M |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$4.37M |
| 3 |
PGA
Portland Global Advisors
Portland,
Maine
|
+$2.52M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$1.16M |
| 5 |
OCM
One Capital Management
Westlake Village,
California
|
+$707K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.38M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$697K |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$577K |
| 4 |
Jane Street
New York
|
-$576K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
-$560K |
GNOM Hedge Fund Activity: Q2 2022 in Review
58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2022, worth a combined $111M — up 65% from $67.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of GNOM and 7 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 17 added.
The largest buyer was Northwestern Mutual Wealth Management, opening a new position worth an estimated $56M. The largest seller was UBS Group, cutting an estimated $3.38M.
- 58 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2022, down from 60 in Q1 2022.
- Funds reported $111M of Global X Genomics & Biotechnology ETF stock for Q2 2022, up 65% quarter-over-quarter.
- 7 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2022 and 9 closed out, a net change of -2 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2022 was Northwestern Mutual Wealth Management, an estimated $56M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2022 was UBS Group, an estimated $3.38M sold.
Based on aggregated 13F filings for Q2 2022.